Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.

Published on Oct 1, 2005in International Journal of Radiation Oncology Biology Physics5.859
· DOI :10.1016/J.IJROBP.2006.03.018
Loren K. Mell52
Estimated H-index: 52
(UIC: University of Illinois at Chicago),
J.D. Kochanski3
Estimated H-index: 3
(UIC: University of Illinois at Chicago)
+ 7 AuthorsArno J. Mundt61
Estimated H-index: 61
(UCSD: University of California, San Diego)
Purpose: To identify dosimetric parameters associated with acute hematologic toxicity (HT) and chemotherapy delivery in cervical cancer patients undergoing concurrent chemotherapy and intensity-modulated pelvic radiotherapy. Methods and Materials: We analyzed 37 cervical cancer patients receiving concurrent cisplatin (40 mg/m 2 /wk) and intensity-modulated pelvic radiotherapy. Pelvic bone marrow (BM) was contoured for each patient and divided into three subsites: lumbosacral spine, ilium, and lower pelvis. The volume of each region receiving 10, 20, 30, and >40 Gy (V10 ,V 20 ,V 30, and V40, respectively) was calculated. HT was graded according to the Radiation Therapy Oncology Group system. Multivariate regression models were used to test associations between dosimetric parameters and HT and chemotherapy delivery. Results: Increased pelvic BM V10 (BM-V10) was associated with an increased Grade 2 or worse leukopenia and neutropenia (odds ratio [OR], 2.09; 95% confidence interval [CI], 1.24‐3.53; p 0.006; and OR, 1.41; 95% CI, 1.02‐1.94; p 0.037, respectively). Patients with BM-V10 >90% had higher rates of Grade 2 or worse leukopenia and neutropenia than did patients with BM-V10 <90% (11.1% vs. 73.7%, p < 0.01; and 5.6% vs. 31.6%, p 0.09) and were more likely to have chemotherapy held on univariate (16.7% vs. 47.4%, p 0.08) and multivariate (OR, 32.2; 95% CI, 1.67‐622; p 0.02) analysis. No associations between HT and V30 and V40 were observed. Dosimetric parameters involving the lumbosacral spine and lower pelvis had stronger associations with HT than did those involving the ilium. Conclusion: The volume of pelvic BM receiving low-dose radiation is associated with HT and chemotherapy delivery in cervical cancer patients undergoing concurrent chemoradiotherapy. © 2006 Elsevier Inc. Intensity-modulated radiotherapy, Bone marrow, Cervical cancer, Hematologic toxicity.
📖 Papers frequently viewed together
190 Citations
135 Citations
154 Citations
34 CitationsSource
#1Nancy N. Baxter (UMN: University of Minnesota)H-Index: 73
#2Elizabeth B. Habermann (UMN: University of Minnesota)H-Index: 50
Last. Beth A Virnig (UMN: University of Minnesota)H-Index: 66
view all 5 authors...
ContextPelvic fractures, including hip fractures, are a major source of morbidity and mortality in older women. Although therapeutic pelvic irradiation could increase the risk of such fractures, this effect has not been studied.ObjectiveTo determine if women who undergo pelvic irradiation for pelvic malignancies (anal, cervical, or rectal cancers) have a higher rate of pelvic fracture than women with pelvic malignancies who do not undergo irradiation.Design, Setting, and ParticipantsWe conducted...
277 CitationsSource
#1Michael T. Milano (U of C: University of Chicago)H-Index: 40
#2Ashesh B. Jani (U of C: University of Chicago)H-Index: 35
Last. Steven J. Chmura (U of C: University of Chicago)H-Index: 36
view all 6 authors...
Purpose: To assess survival, local control, and toxicity of intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the anal canal. Methods and Materials: Seventeen patients were treated with nine-field IMRT plans. Thirteen received concurrent 5-fluorouracil and mitomycin C, whereas 1 patient received 5-fluorouracil alone. Seven patients were planned with three-dimensional anteroposterior/posterior-anterior (AP/PA) fields for dosimetric comparison to IMRT. Results: Compared wi...
191 CitationsSource
#1John C. RoeskeH-Index: 37
#2Anthony E LujanH-Index: 12
Last. Arno J. MundtH-Index: 61
view all 6 authors...
Background and purpose: To incorporate single-photon emission computed tomography (SPECT) bone marrow (BM) imaging into the treatment planning process to reduce the volume of BM irradiated in gynecologic patients receiving intensity-modulated whole-pelvic radiation therapy (IM-WPRT). Materials and methods: A planning CT scan was obtained of a patient with early stage endometrial cancer. The same patient also underwent a Tc-99m sulfur colloid SPECT scan of the pelvis. Tc-99m sulfur colloid is seq...
67 CitationsSource
#1Mylin A. Torres (University of Texas MD Anderson Cancer Center)H-Index: 4
#2Anuja Jhingran (University of Texas MD Anderson Cancer Center)H-Index: 42
Last. Patricia J. Eifel (University of Texas MD Anderson Cancer Center)H-Index: 71
view all 5 authors...
RT, and transfusion during RT) and three descriptive tumor variables (clinical tumor diameter, clinical lymph node status, and FIGO stage) were recorded. Tumor diameters were recorded in 94% of patients and were categorized as 4 cm (1035 pts; 38%), 4–4.9 cm (549 pts; 14%), 5–5.9 cm (499, 18%), 6–6.9 cm (301; 11%), or 7 cm (360 pts; 13%). The median follow-up of surviving patients was 163 months. Comparisons between actuarial curves were made using the log-rank method. A proportional hazards regr...
2 CitationsSource
#1Yi-Jen Chen (City of Hope National Medical Center)H-Index: 14
#2An Liu (City of Hope National Medical Center)H-Index: 26
Last. Jeffrey Y.C. Wong (City of Hope National Medical Center)H-Index: 48
view all 7 authors...
Purpose: To describe a novel and straightforward conformal avoidance intensity-modulated radiation therapy (IMRT) technique for coverage of pelvis and inguinal/femoral nodes and to compare the dosimetry of the new method with that of other traditional methods of radiation treatment. Methods and Materials: Data of 2 patients with anal cancer were used as example cases to illustrate details and advantages of conformal avoidance IMRT technique. Conventional photons with enface electrons design was ...
92 CitationsSource
#1Harry J. Long (Mayo Clinic)H-Index: 39
#2Brian N. BundyH-Index: 30
Last. James V. FioricaH-Index: 31
view all 9 authors...
Purpose On the basis of reported activity of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) or topotecan plus cisplatin in advanced cervix cancer, we undertook a randomized trial comparing these combinations versus cisplatin alone, to determine whether survival is improved with either combination compared with cisplatin alone, and to compare toxicities and quality of life (QOL) among the regimens. Patients and Methods Eligible patients were randomly allocated to receive cisplatin 5...
409 CitationsSource
#1Anesa Ahamad (University of Texas MD Anderson Cancer Center)H-Index: 20
#2Warren D. D'Souza (University of Texas MD Anderson Cancer Center)H-Index: 16
Last. Patricia J. Eifel (University of Texas MD Anderson Cancer Center)H-Index: 71
view all 7 authors...
Purpose: To determine the influence of target-volume expansion on the reduction in small-bowel dose achieved with use of intensity-modulated radiation therapy (IMRT) vs. standard conformal treatment of the pelvis after hysterectomy, and to investigate the influence of patient body habitus on the normal-tissue sparing achieved with use of IMRT. Methods and Materials: A clinical target volume (CTV) was contoured on each of 10 planning computed tomography scans of patients who had been treated for ...
107 CitationsSource
#1Alfonso Dueñas-González (UNAM: National Autonomous University of Mexico)H-Index: 43
#2Lucely Cetina-Pérez (UNAM: National Autonomous University of Mexico)H-Index: 4
Last. Alejandro Mohar (UNAM: National Autonomous University of Mexico)H-Index: 32
view all 12 authors...
Purpose To compare gemcitabine and cisplatin (GC) with cisplatin (C) concurrent with radiotherapy in International Federation of Gynecology and Obstetrics Stage IB2, IIA, and IIB cervical carcinoma in a preoperative setting. The main endpoints were the pathologic response rate and toxicity. Methods and materials A total of 83 patients were randomized to either C or GC. Treatment consisted of six doses of cisplatin at 40 mg/m 2 every week for Arm 1 (C) and six doses of gemcitabine at 125 mg/m 2 p...
59 CitationsSource
#1Joshua J. Haslam (U of C: University of Chicago)H-Index: 1
#2Anthony E Lujan (U of C: University of Chicago)H-Index: 12
Last. John C. Roeske (U of C: University of Chicago)H-Index: 37
view all 5 authors...
Abstract Intensity-modulated whole pelvic radiation therapy (IM-WPRT) has decreased the incidence of gastrointestinal complications by reducing the volume of normal tissue irradiated in gynecologic patients. However, IM-WPRT plans result in steep dose gradients around the target volume, and thus accurate patient setup is essential. To quantify the accuracy of our patient positioning, we examined the weekly portal films of 46 women treated with IM-WPRT at our institution. All patients were positi...
23 CitationsSource
Cited By189
#1Qian Wang (Peking Union Medical College)
#2Qingtao Qiu (Peking Union Medical College)
Last. Baosheng Li (Peking Union Medical College)H-Index: 13
view all 7 authors...
BACKGROUND We analyzed the relationship among peripheral blood lymphocytes, exposed sternum and vertebra body bone marrow (BM), and overall survival (OS) to find BM dosimetric parameters of lymphopenia during chemoradiotherapy (CRT) for patients with esophageal squamous cell carcinoma (ESCC). METHODS We examined 476 ESCC patients from January 2012 to January 2015, all of whom received concurrent or sequential CRT. Absolute lymphocyte counts (ALC) during radiotherapy (RT) of each patient were col...
#1Casey W. Williamson (UCSD: University of California, San Diego)H-Index: 8
Last. Loren K. Mell (UCSD: University of California, San Diego)H-Index: 52
view all 4 authors...
The standard of care for the definitive treatment of locoregionally advanced cervical cancer is external beam radiation therapy (EBRT) with concurrent chemotherapy followed by a brachytherapy boost. Historically, EBRT was delivered via a two-dimensional technique based primarily on bony landmarks. This gave way to three-dimensional conformal radiation therapy, which allows for dose calculation and adjustment based on individual tumour and patient anatomy. Further technological advances have esta...
We investigated the role of the selective avoidance of haematopoietically active pelvic bone marrow (BM), with a targeted intensity-modulated radiotherapy (IMRT) approach, to reduce acute hematologic toxicity (HT) in anal cancer patients undergoing concurrent chemo-radiation. We designed a one-armed two-stage Simon’s design study to test the hypothesis that BM-sparing IMRT would improve by 20% the rate of G0–G2 (vs. G3–G4) HT, from 42% of RTOG 0529 historical data to 62% (α = 0.05; β = 0.20). A ...
1 CitationsSource
#1Wei Huang (CQMU: Chongqing Medical University)
#2Jun Dang (CQMU: Chongqing Medical University)
Last. Qing-feng Jiang (CQMU: Chongqing Medical University)
view all 6 authors...
Background: While chemo-radiotherapy improves local control in patients with locally advanced rectal cancer, it can also increase acute hematological (HT) toxicity, which leads to poor outcomes. Patients receiving bone marrow radiation have been shown to develop acute HT. However, the safety and efficacy of bone marrow sparing is undermined. The aim of our study was to explore the feasible dosimetric constraints for pelvic bone marrow (PBM) that can be widely used in rectal cancer patients under...
Resume La moelle osseuse pelvienne est le siege de pres de 50 % de l’hematopoiese totale. La radiotherapie des aires ganglionnaires pelviennes, et des cancers situes a proximite des structures osseuses du bassin, expose a une toxicite hematologique de l’ordre de 30 a 70 %. Cette toxicite depend de nombreux facteurs, notamment la delivrance ou non d’une chimiotherapie concomitante, ainsi que de son type, des volumes osseux irradies, des doses recues, ou encore de la reserve hematopoietique initia...
#1E. M. Gort (UMCG: University Medical Center Groningen)H-Index: 2
#2Jannet C. Beukema (UMCG: University Medical Center Groningen)H-Index: 19
Last. Charlotte L. Brouwer (UMCG: University Medical Center Groningen)H-Index: 14
view all 8 authors...
Abstract Purpose Large-field photon radiotherapy is current standard in the treatment of cervical cancer patients. However, with the increasing availability of Pencil Beam Scanning Proton Therapy (PBS-PT) and robust treatment planning techniques, protons may have significant advantages for cervical cancer patients in the reduction of toxicity. In this study, PBS-PT and photon Volumetric Modulated Arc Therapy (VMAT) were compared, examining target coverage and organ at risk (OAR) dose, taking int...
3 CitationsSource
#1De-Yang Yu (HMU: Harbin Medical University)
#2Yan-Ling Bai (HMU: Harbin Medical University)
Last. Yunyan Zhang (HMU: Harbin Medical University)H-Index: 4
view all 9 authors...
Background To evaluate the dosimetric parameters of different bone marrow sparing strategies and radiotherapy technologies and determine the optimal strategy to reduce hematologic toxicity associated with concurrent chemoradiation (cCRT) for cervical cancer. Methods A total of 15 patients with Federation International of Gynecology and Obsterics (FIGO) Stage IIB cervical cancer treated with cCRT were re-planned for bone marrow (BM)-sparing plans. First, we determined the optimal BM sparing strat...
#1Tahir Yusufaly (UCSD: University of California, San Diego)H-Index: 7
#2Austin Miller (Roswell Park Cancer Institute)H-Index: 28
Last. Loren K. Mell (UCSD: University of California, San Diego)H-Index: 52
view all 14 authors...
ABSTRACT Background Sparing active bone marrow (ABM) can reduce acute hematologic toxicity in patients undergoing chemoradiotherapy for cervical cancer, but ABM segmentation based on positron emission tomography/computed tomography (PET/CT) is costly. We sought to develop an atlas-based ABM segmentation methods for implementation in a prospective clinical trial. Methods A multi-atlas was built on a training set of 144 patients and validated in 32 patients from the XXX-XXXXX clinical trial. ABM f...
2 CitationsSource
#2Umberto RicardiH-Index: 52
Last. Alan Dal PraH-Index: 15
view all 3 authors...
1 CitationsSource
#2Patrick Silvetti (UNITO: University of Turin)H-Index: 2
Last. Pierfrancesco Franco (UNITO: University of Turin)H-Index: 27
view all 13 authors...
Purpose: to investigate the role of selective avoidance of hematopoietically active BM within the pelvis, as defined with 18FDG-PET, employing a targeted IMRT approach, to reduce acute hematologic toxicity (HT) profile in anal cancer patients undergoing concurrent chemo-radiation. Methods: a one-armed two-stage Simon’s design was selected to test the hypothesis that BM-sparing approach would improve by 20% the rate of G0–G2 (vs. G3–G4) HT, from 42% of RTOG 0529 historical data to 62% (α = 0.05 a...
9 CitationsSource